Matthew Davis

Matthew Davis

Corporate Officer/Principal at AQUESTIVE THERAPEUTICS, INC.

Net worth: 511 000 $ as of 2026-08-30

Health Technology
Consumer Services
Consumer Non-Durables

Profile

Dr. Matthew W.
Davis
, MD, is a Chief Development Officer at Aquestive Therapeutics, Inc. and an Adjunct Associate Professor at Temple University (Pennsylvania).
Dr. Davis was previously employed as a Chief Operating & Medical Officer by Tiziana Life Sciences Ltd. (United Kingdom), a Chief Operating & Medical Officer by Tiziana Life Sciences Ltd. (Bermuda), a SVP-Research & Development Branded Pharmaceuticals by Endo International Plc, a Vice President-Branded Products & Medical Affairs by URL Pharma, Inc., a Head-Medical Affairs by Dermik Laboratories, Inc., a Head-Clinical Development & Medical Affairs by Dr. Reddy's Laboratories, Inc., a Head-Medical Affairs & Pharmacovigilance by Endo Pharmaceuticals, Inc., a Chief Medical Officer by Lupin, Inc., and a Chief Medical Officer by Neuvivo, Inc. He received his undergraduate degree from Temple University School of Pharmacy and a doctorate degree from Drexel University College of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-08 100,000 ( 0.08% ) 511 000 $ 2026-08-30

Matthew Davis active positions

CompaniesPositionStart
AQUESTIVE THERAPEUTICS, INC. Corporate Officer/Principal 2025-11-03
Corporate Officer/Principal -

Former positions of Matthew Davis

CompaniesPositionEnd
TIZIANA LIFE SCIENCES LTD Chief Operating Officer 2024-06-30
Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
Chief Operating Officer -
ENDO INTERNATIONAL PLC Corporate Officer/Principal -
See the detail of Matthew Davis's experience

Training of Matthew Davis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Non-Durables

Health Technology

Health Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology